Beyond Air (XAIR) Share-based Compensation Growth (1y) (2017 - 2026)
Beyond Air (XAIR) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | -30.44% |
| 10 | Beyond Air | 2.13 Mn | -10.23 Mn | 94,000.00 | 105.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.01% |
| Dec 31, 2025 | -87.90% |
| Sep 30, 2025 | -90.41% |
| Jun 30, 2025 | -33.33% |
| Mar 31, 2025 | -144.51% |
| Dec 31, 2024 | -61.48% |
| Sep 30, 2024 | 347.00% |
| Jun 30, 2024 | -95.09% |
| Mar 31, 2024 | 339.53% |
| Dec 31, 2023 | 972.50% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 32.24% |
| Mar 31, 2023 | -33.85% |
| Dec 31, 2022 | -71.64% |
| Sep 30, 2022 | 334.78% |
| Jun 30, 2022 | 280.26% |
| Mar 31, 2022 | 41.46% |
| Dec 31, 2021 | 99.43% |
| Sep 30, 2021 | -86.36% |
| Jun 30, 2021 | -33.03% |